<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Technical Trading Overview for Vivus Inc. (VVUS)</title>
	<atom:link href="http://www.beaconequity.com/technical-trading-overview-for-vivus-inc-vvus/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.beaconequity.com/technical-trading-overview-for-vivus-inc-vvus/</link>
	<description>Penny Stocks, Stock Picks, Stock Alerts, Small Cap Newsletter</description>
	<lastBuildDate>Fri, 12 Mar 2010 01:56:56 +0100</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Avanafil</title>
		<link>http://www.beaconequity.com/technical-trading-overview-for-vivus-inc-vvus/comment-page-1/#comment-3177</link>
		<dc:creator>Avanafil</dc:creator>
		<pubDate>Thu, 24 Dec 2009 16:42:59 +0000</pubDate>
		<guid isPermaLink="false">http://www.beaconequity.com/?p=6134#comment-3177</guid>
		<description>Avanafil looks to be in good form to be approved someday by the FDA. It still needs to be submitted first but its testings look very good. Where it may do well is in its claim to work quickly. As far as the stock is concerned, be advised that Avanafil still needs to be submitted to the FDA. Once this is done it can take around a year after that if it is approved. I don&#039;t see this drug coming out any sooner than 2011 sometime. So if you are hoping to buy this stock and sell it in months, it may not be the best plan. But at around $10 and the fact that VVUS has been over $40. If you are willing to wait it out, it COULD be a winner.</description>
		<content:encoded><![CDATA[<p>Avanafil looks to be in good form to be approved someday by the FDA. It still needs to be submitted first but its testings look very good. Where it may do well is in its claim to work quickly. As far as the stock is concerned, be advised that Avanafil still needs to be submitted to the FDA. Once this is done it can take around a year after that if it is approved. I don&#8217;t see this drug coming out any sooner than 2011 sometime. So if you are hoping to buy this stock and sell it in months, it may not be the best plan. But at around $10 and the fact that VVUS has been over $40. If you are willing to wait it out, it COULD be a winner.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
